HOME > NATION > Article

Text Size

small

medium

large


(Update) Japan Team to Start iPS Clinical Trial for Neck Cancer

(Update) Japan Team to Start iPS Clinical Trial for Neck Cancer

   Tokyo, June 29 (Jiji Press)--Japan's Chiba University and government-linked research body Riken said Monday they will launch a clinical trial to treat head and neck cancer using killer cells produced from induced pluripotent stem, or iPS, cells.
   In the trial led by doctors, the two institutes will create natural killer T, or NKT, cells, which attack cancer cells, from iPS cells and inject them into patients.
   This will be the first clinical trial or research in Japan to use cells made from iPS cells for cancer treatment. Also, an injection of iPS cell-derived NKT cells into humans will be the first in the world.
   The trial will be conducted by a team including Chiba University professor Shinichiro Motohashi.
   "We're trying to establish a new cancer therapy," said Motohashi, a tumor immunology specialist.

To read a full story, please click here to find out how to subscribe.

NATION

Aomori Tourism Information

HEADLINES

POLITICS
Toyama Governor Race to Kick Off on Oct. 8 for Voting on Oct. 25
ECONOMY
Tokyo Area Condo Supply in 2020 1st Half Drops 44% to Record Low of 7,497 Units
SPORTS
Gymnastics Women: Teramoto Steadily Recovering from Achilles Tendon Rupture
OTHER
Haneko Takayama, Haruka Tono Each Win Akutagawa Prize, Seishu Hase Naoki Prize

AFP-JIJI PRESS NEWS JOURNAL


Photos